Markets.com Logo
markets.com

AIMBU

$--
--%
1d
1w
1m

Analysis and statistics

  • Open
    18.2245$
  • Previous Close
    18.2245$
  • 52 Week Change
    9.39$
  • Day Range
    0.00$
  • 52 Week High/Low
    10.01$ - 19.4$
  • Dividend Per Share
    --
  • Market cap
    0$
  • EPS
    --
  • Beta
    -0.237
  • Volume
    --

About

AIMBU.US is a CUSIP for the AIM Ultra Short Bond ETF. It is an exchange-traded fund (ETF) that invests primarily in U.S. dollar-denominated investment-grade fixed-income securities with an average portfolio duration of one year or less. The fund seeks to provide current income while maintaining liquidity and preserving capital.
markets.com
Nasdaq 100 Forecast: Index Tests Critical Resistance Amid Cooler Inflation and Resurgent Geopolitical Risks

Nasdaq 100 Forecast: Index Tests Critical Resistance Amid Cooler Inflation and Resurgent Geopolitical Risks

Julian Parker|--
Precious metals lower, UK shows growth, BoC rate unchanged

Precious metals lower, UK shows growth, BoC rate unchanged

Darius Anucauskas|--
US June CPIs today & BoC rate decision tomorrow

US June CPIs today & BoC rate decision tomorrow

Darius Anucauskas|--
AMD Stock Price Forecast: AI Growth vs Valuation

AMD Stock Price Forecast: AI Growth vs Valuation

Julian Parker|--
Week Ahead: US June inflation and BoC rate decision are on the watch

Week Ahead: US June inflation and BoC rate decision are on the watch

Darius Anucauskas|--
USD/CAD Forecast: Pair Recovers from Three-Week Low Ahead of Canadian Jobs Data

USD/CAD Forecast: Pair Recovers from Three-Week Low Ahead of Canadian Jobs Data

Julian Parker|--
XRP Price Forecast 2026–2030: Can It Reach New Highs?

XRP Price Forecast 2026–2030: Can It Reach New Highs?

Julian Parker|--

Factors

Company Performance: AIM ImmunoTech's success in clinical trials for its drug Ampligen directly impacts the stock price.

Market Sentiment: Overall investor confidence and risk appetite affect demand for biotech stocks like AIMBU.US.

Regulatory Approvals: FDA decisions on Ampligen's approval are major price catalysts.

Competition: Competing therapies in the same disease areas influence AIMBU.US value.

Financial Health: AIM ImmunoTech's cash reserves, debt levels, and burn rate affect investor perception.

Partnerships: Collaborations with other companies can positively impact AIMBU.US stock.

People Also Watch

Latest news

Bitcoin Price Today (July 17): BTC Slips to $63,485.49 as Investors Await Fresh Market Catalysts

Bitcoin Price Today (July 17): BTC Slips to $63,485.49 as Investors Await Fresh Market Catalysts

Daniel Carter|--
USD to JPY Exchange Rate Today (July 17): Dollar Holds Firm as Yen Stays Near Multi-Decade Lows

USD to JPY Exchange Rate Today (July 17): Dollar Holds Firm as Yen Stays Near Multi-Decade Lows

Daniel Carter|--
Gold Price July 17: Spot Plunges Below $4,000 on Fed Bets

Gold Price July 17: Spot Plunges Below $4,000 on Fed Bets

Julian Parker|--

Latest Education Articles

What Is a Stock Index? Everything You Need to Know

What Is a Stock Index? Everything You Need to Know

Julian Parker|--
Index Trading Hours: Best Time to Trade Indices in the UAE

Index Trading Hours: Best Time to Trade Indices in the UAE

Julian Parker|--
Index Trading Strategies for 2026

Index Trading Strategies for 2026

Julian Parker|--
Recommended Topics
markets.com